{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-014561","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2023-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:42.755706+00:00","generated_at":"2026-06-16T05:53:39.148285+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Medifast Q1 revenue down 16.4% to $349M; guides Q2 revenue $250-270M, EPS $1.32-1.44","bullets":["Revenue $349M (-16.4% YoY); net income $40M ($3.67 diluted EPS) vs $41.8M ($3.59) prior year.","Active earning OPTA VIA coaches 58,700 (-8.1%); revenue per coach $5,945 (-9.0%).","Gross profit margin 70.6% vs 72.4% due to cost inflation and lower volumes.","Q2 2023 guidance: revenue $250-270M, diluted EPS $1.32-1.44, effective tax rate 24.5-26.25%.","Quarterly dividend $1.65/share payable May 9; cash $123.7M, no debt."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-014561","json":"https://secwatch.observer/filing/0001628280-23-014561.json","markdown":"https://secwatch.observer/filing/0001628280-23-014561.md","text":"https://secwatch.observer/filing/0001628280-23-014561.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000162828023014561/0001628280-23-014561-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000162828023014561/med-20230501.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T05:53:39.148285+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8a9de7b739be55e1a8420749d047f2172a46a82b","claim":"MEDIFAST INC reported the first quarter ended March 31, 2023 results: revenue $349.0 million, net income $40.0 million, EPS $3.67 per diluted share.","evidence_excerpt":"Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA® , today reported results for the first quarter ended March 31, 2023. First Quarter 2023 • Revenue of $349.0 million, with revenue per active earning coach of $5,945 • Independent active earning OPTA VIA Coaches of 58,700 • Net income of $40.0 million • Earnings per diluted share (“EPS”) of $3.67","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828023014561/0001628280-23-014561-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2023"},{"label":"Revenue","value":"$349.0 million"},{"label":"Net income","value":"$40.0 million"},{"label":"EPS","value":"$3.67 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}